MRX Medical is an innovative company which formulates and manufactures novel and proprietary cannabinoid medicines. Our focus is on quality, consistency and evidence.
Enquire about productsProducts manufactured using pharmaceutical grade ingredients.
Manufactured in the UK to EU GMP requirements.
Proven in laboratory tests to be consistent from batch to batch.
First product being used in two Phase II Randomised Controlled Trials.
Yes, cannabis-based products for medicinal use (CBPMs) have been legal in the UK since November 2018.
No. As a cannabis-based product for medicinal use (CBPM), MRX products are only available via a private consultation with a specialist.
In the UK, cannabis-based products for medicinal use (CBPMs) are accessible via a private consultation with a doctor who specialises in your type of condition. CBPMs are primarily accessed via private clinics in the UK, but they can be prescribed by any specialist physician.
You should choose a clinic that is going to work for you and has a doctor(s) specialising in your condition. The Medical Cannabis Clinicians Society has compiled a list of CQC-registered medical cannabis clinics and independent prescribers operating in the UK, which is available here.
Cannabinoid medicines can be taken in various forms depending on the needs of the patient and these should be discussed between patient and doctor. MRX develops sublingual cannabinoid oils, which are taken under the tongue.
Patients are able to use any pharmacy that supplies the appropriate medicines in the UK. Some clinics may have a preferred pharmacy, but they are obliged to allow patients a free choice in pharmacy.
Over-the-counter (OTC) CBD products are not the same as cannabis-based products for medicinal use (CBPMs) like MRX oils.
CBPMs can only be prescribed by specialist doctors and are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) to ensure their safety, quality and effectiveness. They must be produced to ‘Good Manufacturing and Distribution Practices’ by manufacturers that are accredited by the medicines regulator and are classified as pharmaceutical-grade medicines.
OTC products can be purchased without a prescription and are not subject to the same regulations. They are not medicinal products and are regulated separately by the Food Standards Agency as a food supplement.
No. MRX currently only provides its cannabinoid medicines as unlicensed medicines, which means that they must be written on a private prescription.
There are currently only 3 licensed medicines in the UK which contain cannabinoids: Epidiolex for some rare forms of Epilepsy, Sativex for Multiple Sclerosis and Nabilone for chemotherapy-induced nausea and vomiting.
Medical cannabis products can currently be considered for use for a number of indications and can be prescribed by a specialist clinician for diagnosed conditions where first line therapies have failed.
No. MRX are only available on prescription via a private consultation with a doctor who specialises in your type of condition.
MRX Medical is bound by UK laws governing the promotion and advertising of medicines. Under regulation 279 of Part 14 of the Human Medicines Regulations 2012, medicines that do not hold a marketing authorisation (i.e. unlicensed medicines) cannot be advertised for medicinal purposes. MRX is therefore unable by law to provide information to the public regarding its unlicensed medicinal products.
Yes, healthcare professionals can get in contact with us via the form on this website or by emailing info@mrxmedical.com.
Patients should speak to their specialist regarding the appropriate medicine and dosage regimen for their condition and circumstances.
Further information on pricing will be available through your specialist.